Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Cross-sectional studies show that elevated cerebral amyloid is associated with greater white-matter hyperintensity (WMH) burden in cognitively normal (CN) older adults. However, the relative time courses of amyloid and WMH accrual are unclear. To address this, we tested the associations between known WMH correlates—age, hypertension, and amyloid—with WMH accrual rate. We used brain magnetic resonance imaging to measure WMH change in 112 CN Alzheimer’s Disease Neuroimaging Initiative (GO/2) participants over a 2-year period. A linear mixed effects model assessed baseline cerebrospinal fluid amyloid beta (Aβ) 1–42, hypertension, age, and their interactions, as predictors of greater WMH accrual. Greater amyloid burden was associated with greater WMH accrual over time. Those with hypertension showed a stronger association between greater amyloid burden and WMH accrual rate. Greater age was not significantly associated with greater WMH accrual in this model. Although the direction of the relationship cannot be tested in this model, CN individuals harboring cerebral amyloid had greater accrual of WMH over a 2-year period after accounting for hypertension and age. Impaired amyloid clearance and cerebral small vessel disease may both underlie the more rapid emergence of WM lesions. The role of cerebral amyloid burden in white-matter injury should thus be considered as a relevant factor when WMHs are detected clinically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations
Gouw, A. A., Seewann, A., van der Flier, W. M., Barkhof, F., Rozemuller, A. M., Scheltens, P., & Geurts, J. J. G. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.204685 · Cited by 766
β-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703 · cited 2×
“However, cerebral amyloidosis can also interfere with perfusion of the brain by damaging perivascular spaces among other processes (Thomas et al., 1996).”
Comparing predictors of conversion and decline in mild cognitive impairment
Landau, S. M., Harvey, D., Madison, C. M., Reiman, E. M., Foster, N. L., Aisen, P. S., Petersen, R. C., Shaw, L. M., Trojanowski, J. Q., Jack, C. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e8e8b8 · Cited by 616
Self-citationProvenzano, F. A., Muraskin, J., Tosto, G., Narkhede, A., Wasserman, B. T., Griffith, E. Y., Guzman, V. A., Meier, I. B., Zimmerman, M. E., Brickman, A. M., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1321 · Cited by 192
Godin, O., Tzourio, C., Maillard, P., Mazoyer, B., & Dufouil, C. (2011) · Circulation · doi:10.1161/circulationaha.110.961052 · Cited by 187 · cited 1×
“Given that over 90% of participants were actively treated for hypertension, our data suggest that this approach is effective in reducing the accrual of WMH, which is in agreement with past studies (Godin et al., 2011).”
Self-citationLongitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
Toledo, J. B., Xie, S. X., Trojanowski, J. Q., & Shaw, L. M. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1151-4 · Cited by 180 · cited 1×
“In CN older adults, hypertension and elevated cerebral amyloid are common, but few studies have questioned the independent and interacting associations of each with WMH burden (Toledo et al., 2013).”
Amyloid-β 11 C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
Liu, E., Schmidt, M. E., Margolin, R., Sperling, R., Koeppe, R., Mason, N. S., Klunk, W. E., Mathis, C. A., Salloway, S., Fox, N. C., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001877 · Cited by 151 · cited 1×
“Targeting amyloid is a promising approach demonstrated by recent advances in the development of anti-amyloid therapeutics (D ’ Avanzo et al., 2015; Liu et al., 2015; Lovell et al., 2016).”
Regional pattern of white matter microstructural changes in normal aging, MCI, and AD
Lee, D. Y., Fletcher, E., Martinez, O., Ortega, M., Zozulya, N., Kim, J., Tran, J., Buonocore, M., Carmichael, O., & DeCarli, C. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c33afb · Cited by 122 · cited 1×
“However, we extended this fi nding to show that the presence of cerebral amyloidosis mitigates this therapeutic effect and results in the greatest amount of WMH accrual over the 2-year period, despite highly compliant treatment of hypertension (Lee et al., 2009).”
Self-citationInteraction between cerebrovascular disease and Alzheimer pathology
Saito, S., & Ihara, M. (2016) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000239 · Cited by 69
Cited by
Veitch, D. P., Weiner, M. W., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Morris, J. C., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.005 · Cited by 454
Self-citationMcAleese, K. E., Walker, L., Graham, S., Moya, E. L. J., Johnson, M., Erskine, D., Colloby, S. J., Dey, M., Martin-Ruiz, C., Taylor, J.-P., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1738-2 · Cited by 273
Self-citationWeaver, N. A., Doeven, T., Barkhof, F., Biesbroek, J. M., Groeneveld, O. N., Kuijf, H. J., Prins, N. D., Scheltens, P., Teunissen, C. E., van der Flier, W. M., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.001 · Cited by 71
White matter hyperintensities are associated with subthreshold amyloid accumulation
Moscoso, A., Rey-Bretal, D., Silva-Rodríguez, J., Aldrey, J. M., Cortés, J., Pías-Peleteiro, J., Ruibal, Á., & Aguiar, P. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116944 · Cited by 49
“…only 2 out of 13 studies reported a positive correlation between amyloid and WMH burden, in contrast to the multiple CSF studies which found a positive association (see, for instance (Kandel et al., 2016; Marnane et al., 2016; Pietroboni et al., 2018; Scott et al., 2016; Scott et al., 2015),).”
Newton, P., the BIOCARD Research Team, Tchounguen, J., Pettigrew, C., Lim, C., Lin, Z., Lu, H., Moghekar, A., Albert, M., & Soldan, A. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-220846 · Cited by 23
Metadata
- Authors
- Scott, J. A., Braskie, M. N., Tosun, D., Maillard, P., Thompson, P. M., Weiner, M., DeCarli, C., & Carmichael, O. T.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 48
- Pages
- 48-52
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2510861257
- Cited by
- 39
- References
- 12
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2016.08.014
- The paper
- Scott, J. A., Braskie, M. N., Tosun, D., Maillard, P., Thompson, P. M., Weiner, M., DeCarli, C., & Carmichael, O. T. (2016). Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2016.08.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.